Background: Patients with head and neck cancers (HNCs) are at increased risk of experiencing malnutrition, which is associated with poor outcomes. Advances in the treatment of HNCs have resulted in improved outcomes that are associated with severe toxic oral side effects, placing patients at an even greater risk of malnutrition. Prophylactic placement of percutaneous endoscopic gastrostomy (PEG) tubes before treatment may be beneficial in patients with HNC, especially those undergoing more intense treatment regimens. PEG tube placement, however, is not without risks. Methods: A comprehensive review of the literature was conducted. Results: Systematic evidence assessing both the benefits and harm associated with prophylactic PEG tube placement in patients undergoing treatment for HNC is weak, and benefits and harm have not been established. Conclusions: More research is necessary to inform physician behavior on whether prophylactic PEG tube placement is warranted in the treatment of HNC.
BassettMRDobieRA. Patterns of nutritional deficiency in head and neck cancer. Otolaryngol Head Neck Surg. 1983;91:119-125.
6.
Martin VillaresCSan Roman CarbajoJFernandez PelloME. Nutritional status in head and neck cancer patients: the impact on the prognosis. Nutr Hosp. 2003;18:91-94.
7.
LeesJ. Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre. Eur J Cancer Care. 1999;8:133-136.
MangarSSlevinNMaisKSykesA. Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: a retrospective review. Radiother Oncol. 2006;78:152-158.
10.
RavascoPMonteiro-GrilloIVidalPMCamiloME. Nutritional deterioration in cancer: the role of disease and diet. Clin Oncol. 2003;15:443-450.
11.
HenkJM. Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity. Clin Oncol (R Coll Radiol). 1997;9:308-312.
12.
PauloskiBRLogemannJAFoxJCColangeloLA. Biomechanical analysis of the pharyngeal swallow in post-surgical patients with anterior tongue and floor-of-mouth resection and distal flap reconstruction. J Speech Hear Res. 1995;38:110-123.
13.
HillmanREWalshMJWolfGTFisherSGHongWK. Functional outcomes following treatment for advanced laryngeal cancer, part I: voice preservation in advanced laryngeal cancer; part II: laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol. 1998;107:2-27.
14.
MurryTMadasuRMartinARobbinsKT. Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer. Head Neck. 1998;20:31-37.
15.
NewmanLARobbinsKTLogemannJA. Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation. Head Neck. 2002;24:68-77.
16.
NewmanLAVieiraFSchwiezerV. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 1998;124:589-592.
17.
AdelsteinDJSaxtonJPLavertuP. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in respectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck. 1997;19:567-575.
18.
LazurasCLLogemannJAPauloskiBR. Swallowing and tongue functions following treatment for oral and oropharyngeal cancer. J Speech Lang Hear Res. 2000;43:1011-1023.
19.
EisbruchALydenTBradfordCR. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2002;35:23-28.
20.
LazarusCLLogemannJAPauloskiBR. Swallowing disorders in HNC patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope. 1996;106(9 pt 1):1157-1166.
21.
DejangerEGoethalsP. Deglutition disorder as a late sequel of radiotherapy for a pharyngeal tumor. Am J Gastroenterol. 1994;90:493-495.
22.
KotzTAbrahamSBeitlerJWadlerSSmithRV. Pharyngeal transport dysfunction consequent to an organ-sparing protocol. Arch Otolaryngol Head Neck Surg. 1999;125:410-413.
23.
MittalBBPauloskiBRHarafDJ. Swallowing dysfunction—preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys. 2003;57:1219-1230.
24.
HarariPMRitterMAPetereitDGMehtaMP. Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations. Curr Prob Cancer. 2004;28:7-40.
25.
LogemannJAPauloskiBRRademakerAW. Swallowing disorders in the first year after radiation and chemoradiation. Head Neck. 2008;30:148-158.
26.
BonnerJAHarariPMGiraltJ. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New Engl J Med. 2006;354:567-578.
27.
MendenhallWMParsonsJT. Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck. Cancer Invest. 1998;16:594-603.
28.
ParsonsJTMendenhallWMCassisiNJIsaacsJHMillionRR. Hyperfractionation for head and neck cancer. Int J Radiat Oncol Biol Phys. 1988;14:649-658.
29.
GardenASAsperJAMorrisonWH. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?Cancer. 2004;100:1171-1178.
30.
CohenEELingenMWVokesEE. The expanding role of systemic therapy in head and neck cancer. J Clin Oncol. 2004;22:1743-1752.
31.
BrizelDMAlbersMEFisherSR. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798-1804.
32.
PignonJPBourhisJDomengeCDesigneL. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000;355:945-955.
33.
FuKKPajakTFTrottiA. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7-16.
MickRVokesEEWeichselbaumRRPanjeWR. Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy. Otolaryngol Head Neck Surg. 1991;105:62-73.
36.
BrookesGBCliffordP. Nutritional status and general immune competence in patients with head and neck cancer. J R Soc Med. 1981;74:132-139.
37.
Van Bokhorst-de van der Schuervan LeeuwenPAKuikDJ. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer. 1999;86:519-527.
38.
PajakTFLaramoreGEMarcialVA. Elapsed treatment days—a critical item for radiotherapy quality control review in head and neck trials: RTOG report. Int J Radiat Oncol Biol Phys. 1991;20:13-20.
39.
GargSYooJWinquistE. Nutritional support for head and neck cancer patients receiving radiotherapy: a systemic review. Support Care Cancer. 2010;18:667-677.
AugustDAHuhmannMB; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N) Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation, 2009. JPEN J Parenter Enteral Nutr. 2009;33:472-500.
42.
RabeneckLWrayNPPetersenNJ. Long-term outcomes of patients receiving percutaneous endoscopic gastrostomy tubes. J Gen Intern Med. 1996;11:287-293.
43.
MurayamaKM. Enteral feeding tube placement in head and neck cancer patients: special considerations. Nutr Clin Pract. 1997;12(suppl 1):S34-S37.
44.
HunterAM. Nutrition management of patients with neoplastic disease of the head and neck treated with radiation therapy. Nutr Clin Pract. 1996;11:157-169.
45.
LeeJHMachtayMUngerLD. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:871-875.
46.
RustomIKJebreelATayyabMEnglandRJStaffordND. Percutaneous endoscopic, radiological and surgical gastrostomy tubes: a comparison in head and neck cancer patients. J Laryngol Otol. 2006;120:463-466.
47.
RaykherARussoLSchattnerMSchwartzLScottBShikeM. Enteral nutrition support of head and neck cancer patients. Nutr Clin Pract. 2007;22:68-73.
48.
GrantDGBradleyPTPothierDD. Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-institution study, systematic review and meta-analysis. Clin Otolaryngol. 2009;34:103-112.
49.
GaudererMWPonskyJLIzantRJ. Gastrostomy without laparostomy: a percutaneous endoscopic technique. J Pediatr Surg. 1980;15:872-875.
50.
PonskyJLGaudererMW. Percutaneous endoscopic gastrostomy: a nonoperative technique for feeding gastrostomy. Gastrointest Endosc. 1981;27:9-11.
HustonJ. Prophylactic gastrostomy tubes in head and neck cancer patients—a time out project. J Hum Nutr Diet. 2004;17:575-578.
53.
TakwoingiYMDempsterJH. A simple technique for nasogastric feeding tube insertion. Eur Arch Otorhinolaryngol. 2005;262:423-425.
54.
ColettiDGenuitTOrdREngroffS. Metastasis to the percutaneous endoscopic gastrostomy site in the patient with head and neck cancer: a case report and review of the literature. J Oral Maxillofac Surg. 2006;64:1149-1157.
55.
AhmedKASamantSVieraF. Gastrostomy tubes in patients with advanced head and neck cancer. Laryngoscope. 2005;115:44-47.
56.
ColasantoJMPrasadPNashMADeckerRHWilsonLD. Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology. 2005;19:371-379.
57.
WoodK. Audit of nutritional guidelines for head and neck cancer patients undergoing radiotherapy. J Hum Nutr Diet. 2005;18:343-351.
58.
CadyJ. Nutritional support during radiotherapy for head and neck cancer: the role of prophylactic feeding tube placement. Clin J Oncol Nurs. 2007;11:875-880.
59.
RiegerJMZalmanowitzJGWolfaardtJF. Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature. Int J Oral Maxillofac Surg. 2006;35:581-587.
60.
RaykherACorreaLRussoL. The role of pretreatment percutaneous endoscopic gastrostomy in facilitating therapy of head and neck cancer and optimizing the body mass index of the obese patient. JPEN J Parenter Enteral Nutr. 2009;33;404-410.
61.
LawsonJDGaultneyJSabaNGristWDavisLJohnstonePAS. Percutaneous feeding tubes in patients with head and neck cancer: rethinking prophylactic placement for patients undergoing chemoradiation. Am J Otolaryngol. 2009;30:244-249.
62.
McLaughlinBTGokhaleASShuaiY. Management of patients treated with chemoradiotherapy for head and neck cancer without prophylactic feeding tubes: the University of Pittsburgh experience. Laryngoscope. 2010;120:71-75.
63.
FuchsVRGarberAM. The new technology assessment. N Engl J Med. 1990;323:673-677.
64.
CasarettDKapoJCaplanA. Appropriate use of artificial nutrition and hydration—fundamental principles and recommendations. N Engl J Med. 2005;353:2607-2612.
65.
MurphyBAChenACurranWJ. Longitudinal oncology registry of head and neck carcinoma (LORHAN): initial supportive care findings. Support Care Cancer. 2009;17:1393-1401.
66.
RademakerAWVoneshEFLogemannJA. Eating ability in head and neck cancer patients after treatment with chemoradiation: a 12-month follow-up study accounting for dropout. Head Neck. 2003:25:1035-1041.
67.
StatonJRobbinsKTNewmanLSamantSSebelikMVieiraF. Factors predicting poor outcome after chemoradiation for advanced laryngeal cancer. Otolaryngol Head Neck Surg. 2002;127:43-47.
68.
KiesMSHarafDJRosenF. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol. 2001;19:1961-1969.
69.
AckerstaffAHTanIBRaschCR. Quality of life assessment after supradose selective intraarterial cisplatin and concomitant radiation for postoperative stage 4 head and neck cancer. Arch Otolaryngol Head Neck Surg. 2002;128:1185-1190.
70.
SamantSKumarPWanJ. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function. Head Neck. 1999;21:595-601.
71.
NguyenNPMoltzCCFrankC. Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol. 2004;15:383-388.
72.
SmithRVKotzTBeitlerJJWadlerS. Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea: initial results. Arch Otaryngol Head Neck Surg. 2000;126:384-389.
73.
ShileySGHargunaniCASkonerJMHollandJMWaxMK. Swallowing function after chemoradiation for advanced stage oropharyngeal cancer. Otaryngol Head Neck Surg. 2006;134:455-459.
74.
AbitbolAAbdei-WahabMHarveyM. Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) and amifostine (ethyol) in head and neck squamous cell carcinomas: a-3 protocol. Am J Clin Oncol. 2005;28:449-455.
75.
GoguenLAPosnerMRNorrisCM. Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg. 2006;134:916-922.
76.
ChengSSTerrellJEBradfordCR. Variables associated with feeding tube placement in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132:655-661.
77.
MachtayMMoughanJTrottiA. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582-3589.
78.
GardenASHarrisJTrottiA. Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys. 2008;71:1351-2355.
79.
CaudellJJSchanerPEMeredithRF. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 2009;73:410-415.
80.
HutchesonKABarringerDARosenthalDIMayAHRobertsDBLewinJS. Swallowing outcomes after radiotherapy for laryngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2008;134:178-183.
81.
GardineRLKokalWABeattyJDRiihimakiDUWagmanLDTerzJJ. Predicting the need for prolonged enteral supplementation in the patient with head and neck cancer. Am J Surg. 1998;156:63-65.
82.
RieraLSandiumengeACalvoC. Percutaneous endoscopic gastrostomy in head and neck cancer patients. ORL J Otorhinolaryngol Relat Spec. 2002;64:32-34.
83.
RighiPDReddyDKWeisbergerEC. Radiologic percutaneous endoscopic gastrostomy: results in 56 patients with head and neck cancer. Laryngoscope. 1998;108:1020-1024.
84.
McRackanTRWatkinsJMHerrinAE. Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope. 2008;118:1180-1185.
85.
PoulsenMGRiddleBKellerJPorcedduSVTripconyL. Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone. Radiother Oncol. 2008;87:253-259.
86.
LeeHHavrilaCBravoV. Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma. Support Care Cancer. 2008;16:285-289.
87.
SchweinfurthJMBogerGNFeustelPJ. Preoperative risk assessment for gastrostomy tube placement in head and neck cancer patients. Head Neck. 2001;23:376-382.
88.
Al-OthmonMOAmdurRJMorrisCGHinermanRWMendenhallWM. Does feeding tube placement predict for long-term swallowing disability after radiotherapy for head and neck cancer?Head Neck. 2003;25:741-747.
89.
ChepehaDBAnnichGPynnonenMA. Pectoralis major myocutaneous flap vs. revascularized free tissue transfer: complications, gastrostomy tube dependence, and hospitalization. Arch Otolaryngol Head Neck Surg. 2004;130:181-186.
90.
NaikADAbrahamNSRocheVMConcatoJ. Predicting which patients can resume oral nutrition after percutaneous endoscopic gastrostomy tube placement. Aliment Pharmacol Ther. 2005;21:1155-1161.
91.
BensadounRJBenezeryKDassonvilleO. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouacil chemotherapy (BIRCF) in unrestrictable pharyngeal carcinoma: results at 2 years (FNCLCC-GORTEC). Int J Radiat Oncol Biol Phys. 2006;64:983-984.
92.
PreussSFQuanteGSemrauR. An analysis of surgical complications, morbidity, and cost calculation in patients undergoing multimodal treatment for operable oropharyngeal carcinoma. Larygoscope. 2007;117:101-105.
93.
FuaTFCorryJMilnerAD. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: clinical correlation of dose to the pharyngo-esophageal axis and dysphagia. Int J Radiat Oncol Biol Phys. 2007;67:976-981.
94.
BeaverMEMathenyKERobertsDBMyersJN. Predictors of weight loss during radiation therapy. Otolaryngol Head Neck Surg. 2001;125:645-648.
95.
ScolapioJSSpanglerPRRomanoMMMcLaughlinMPSalassaJR. Prophylactic placement of gastrostomy feeding tubes before radiotherapy in patients with head and neck cancer: is it worthwhile?J Clin Gastroenterol. 2001;33:215-217.
96.
PeznerRDArchambeauJOLipsettJAKokalWAThayerWHillLR. Tube feeding enteral nutritional support in patients receiving radiation therapy for advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1987;13:935-939.
97.
TyldesleySSheehanFMunkP. The use of radiologically placed gastrostomy tubes in head and neck cancer patients receiving radiotherapy. Int J Radiation Oncology Biol Phys. 1996;36:1205-1209.
98.
SchattnerMAWillisHJRaykherA. Long-term enteral nutrition facilitates optimization of body weight. JPEN J Parenter Enteral Nutr. 2005;29:198-203.
99.
SalasSBaumstarck-BarrauKAlfonsiM. Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trial. Radiother Oncol. 2009;93:503-509.
100.
EhrssonYTLangius-IklofABarkTLaurellG. Percutaneous endoscopic gastrostomy (PEG)—a long-term follow-up study in head and neck cancer patients. Clin Otolaryngol Allied Sci. 2004;29:740-746.
101.
RustomIKJebreelATayyabMEnglandRJStaffordND. Percutaneous endoscopic, radiological and surgical gastrostomy tubes: a comparison study in head and neck cancer patients. J Laryngol Otol. 2006;120:463-466.
102.
BaredesSBehinDDeitchE. Percutaneous endoscopic gastrostomy tube feeding in patients with head and neck cancer. Ear Nose Throat J. 2004;83:417-419.
103.
HujalaKSipilaJPulkkinenJGrenmanR. Early percutaneous endoscopic gastrostomy nutrition in head and neck cancer patients. Acta Oto Laryngol. 2004;124:847-850.
104.
LinHSIbrahimHZKhengJWFeeWETerrisDJ. Percutaneous endoscopic gastrostomy: strategies for prevention and management of complications. Laryngoscope. 2001;111:1847-1852.
105.
SchattnerMAWillisHJRaykherA. Long-term enteral nutrition facilitates optimization of body weight. JPEN J Parenter Enteral Nutr. 2005;29:198-203.
106.
SiddiqiAMHamiltonRDMinochaA. Malignant seeding of percutaneous endoscopic gastromy tract in patients with head and neck cancer. Am J Med Sci. 2008;336:291-292.
107.
WiggenraadRGFliermanLGoossensA. Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study. Clin Otolaryngol. 2007;32:384-390.
108.
ColettiDGenuitTOrdREngroffS. Metastasis to the percutaneous endoscopic gastrostomy site in the patient with head and neck cancer: a case report and review of the literature. J Oral Maxillofac Surg. 2006;64:1149-1157.
109.
WaltonGM. Complications of percutaneous gastronomy in patients with head and neck cancer–an analysis of 42 consecutive patients. Ann R Coll Surg Engl. 1999;81:272-276.
110.
CunliffeDRSwantonCWhiteCWatt-SmithSRCookTAGeorgeBD. Percutaneous endoscopic gastrostomy at the time of tumour resection in advanced oral cancer. Oral Oncol. 2000;36:471-473.
111.
DouglasJGKohWLaramoreGE. Metastasis to a percutaneous gastronomy site from head and neck cancer-radiobiologic considerations. Head Neck. 2000;22:826-830.
112.
DeurlooEESchultze KoolLJKrögerRvan CoevordenFBalmAJ. Percutaneous radiological gastrostomy in patients with head and neck cancer. Eur J Surg Oncol. 2001;27:94-97.
113.
SinclairJJScolapioJSStarkMEHinderRA. Metastasis of head and neck carcinoma to the site of percutaneous endoscopic gastrostomy: case report and literature review. JPEN J Parenter Enteral Nutr. 2001;25:282-285.
114.
BhamaJKHaasMKFisherWE. Spread of a pharyngeal cancer to the abdominal wall after percutaneous endoscopic gastrostomy. Surg Laparosc Endosc Percutan Tech. 2001;11:375-378.
115.
NeeffMCrowderVLMcIvorNPChaplinJMMortonRP. Comparison of the use of endoscopic and radiologic gastrostomy in a single head and neck cancer unit. ANZ J Surg. 2003;73:590-593.
116.
AdelsonRTDucicY. Metastatic head and neck carcinoma to a percutaneous endoscopic gastrostomy site. Head Neck. 2005;27:339-343.
117.
EzeNJeffordJMWolfDWilliamsonPNeildP. PEG and RIG tube feeding in Head and Neck patients: a retrospective review of complications and outcome. J Eval Clin Pract. 2007;13:817-819.
118.
RaynorEMWilliamsMFMartindaleRGPorubskyES. Timing of percutaneous endoscopic gastrostomy tube placement in head and neck cancer patients. Otolaryngol Head Neck Surg. 1999;120:479-482.
119.
GurneyTAEiseleDWOrloffLAWangSJ. Predictors of quality of life after treatment for oral cavity and oropharyngeal carcinoma. Otolaryngol Head Neck Surg. 2008;139:262-267.
120.
TerrellJERonisDLFowlerKE. Clinical predictors of quality of life in patients with head and neck cancer. Archiv Otolaryngol Head Neck Surg. 2004;130:401-408.
121.
ChanduASmithACRogersSN. Health-related quality of life oral cancer: a review. J Oral Maxillofac Surg. 2006;64:495-502.
122.
RobergeCTranMMassoudC. Quality of life and home enteral tube feeding: a French prospective study in patients with head and neck or oesophageal cancer. Br J Cancer. 2000;82:263-269.
123.
RingashJLockwoodGO’SullivanB. Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial. Radiother Oncol. 2008;87:181-187.
124.
MekhailTMAdelsteinDJRybickiLALartoMASaxtonJPLavertuP. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?Cancer. 2001;91:1785-1790.
125.
RosenthalDILewinJSEisbruchA. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol. 2006;24:2636-2643.
126.
RabinovitchRGrantBBerkeyBA. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03. Head Neck. 2006;28:287-293.
127.
SanabriaACarvalhoALKowalskiLP. Is nutrition support related to a poor prognosis in head and neck cancer patients? Thoughts about the secondary analysis of RTOG trial 90-03. Head Neck. 2007;29:519-520.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
